MarketInOut Stock Screener Log In | Sign Up
 

Hypera S/A ADR

OTC • Healthcare • Drug Manufacturers - Specialty & Generic • Quote as of 09/16/2026 15:59
Hypera S/A ADR stock price and volume chart

Company Profile

IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeOTC
Market Capitalization3,231.34 mln
Float306 mln
Earnings Date10/27/2026

EPS

0.52
Decent

P / E

8.70
Undervalued

Piotroski F-Score

8 / 9
Very strong

Beneish M-Score

-2.54
Likely reliable

Relative Strength

85 / 100
Strongly outperforming

Debt / Equity

0.52
Moderate leverage

Business Description

Hypera S.A. is a Brazilian pharmaceutical company founded in 1999 and based in São Paulo, offering a wide range of consumer health products across many categories. These include pain relief, cold and flu treatments, digestive aids, skin care, vitamins, herbal remedies, antiseptics, and generic medicines, sold under dozens of well-known local brands. Originally called Hypermarcas S.A., the company adopted its current name in 2018.

Key Fundamentals

EPS0.52
P/E8.70
ROE13.37
RPS2.44
ROIC11.94
ROA6.93
Interest Cover2.39
EBITDA, mln573
EV / EBITDA6.91
EV / EBIT7.76
Revenue, mln1,667
EV / Revenue2.37

Financial Strength

Altman Z-Score1.68
Piotroski F-Score 8 / 9
Beneish M-Score-2.54
Price to Intrinsic Value0.65
Price to Graham Number1.55
Shiller PE Ratio8.67

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 2.25% 82 / 100   
1 Month 9.66% 84 / 100   
2 Months 12.84% 76 / 100   
6 Months 14.49% 71 / 100   
1 Year 7.21% 52 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Contact Us